We read with great interest the correspondence entitled “Is a hybrid skin cancer surveillance service for organ transplant recipients feasible? Lessons from the COVID-19 pandemic.”1 We would like to commend the authors for presenting an important adaptive strategy in a particularly vulnerable patient population, with the potential to preserve surveillance capacity for clinically relevant lesions, including lesions that may be suspicious for basal cell carcinoma. The COVID-19 pandemic posed an unprecedented global challenge, especially for immunosuppressed populations such as solid organ transplant recipients. Transplant centers were required to rapidly reorganize clinical practices while continuing life-saving procedures under conditions of considerable uncertainty.
Toplu et al. (2026) studied this question.